G6PD and neoplasm: In support of this, analysis of the TCGA PanCancer Atlas dataset, a very large dataset with transcriptomics on 494 primary tumor samples from 494 patients (15), revealed a significant association between high G6PD expression and a reduction in disease-free survival.